About Clene, Inc. 
Clene, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 4 Schemes (2.53%)
Foreign Institutions
Held by 6 Foreign Institutions (0.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Dec 2025)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 70 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.80
213.67%
-5.68






